BSX Boston Scientific Stock Outlook 2026: 17% Revenue Growth, 47% Stock Drop — What Gives?
Boston Scientific (BSX) stock analysis 2026: TTM revenue $20.6B growing 17.4%, P/E 24.2x, 52-week range $52.52–$109.50, analyst target $83.47, WATCHMAN FLX growth, and EP system competitive dynamics.
BSX Boston Scientific Medical Devices